Search results for: Determining Value
Filter search results
How Much Should Society Pay for a New Orphan Drug? A Contribution to this Debate is now Available in a New OHE Research Paper
18 July 2018
…rare conditions and, if so, how much. Rather, the authors’ approach is one way of determining the maximum allowable price society should be willing to pay, based on allowing a…
Why Should Economic Evaluations of Medical Innovations Have a Societal Perspective?
1 October 2009
In this Briefing, five leading European experts in health economics provide a comprehensive international review of changes in health economic evaluation and the reasons for them. The authors express concern…
The Publicly Funded Vaccines Market in Australia
1 October 2010
This research reviews how vaccines other than for travel or influenza are evaluated, procured and delivered in Australia. It includes observations as to whether and how the economic assessment process…
The Publicly Funded Vaccines Market in the UK
1 October 2010
This research reviews how vaccines other than for travel or influenza are evaluated, procured and delivered in the UK. It includes observations as to whether and how the economic assessment…
Researching the Relative Efficacy and Relative Effectiveness of Medicines across Europe
1 October 2010
Ten member companies of the EFPIA HTA Task Force commissioned OHE consulting to provide research, data and analysis that would enable EFPIA both to support and develop its policy position…
Pharmaceutical Industry and Society: a Study of the Changing Environment and Economics of the International Industry
1 July 1972
This paper is based on a symposium held at the Imperial College of Science and Technology by the Office of Health Economics in 1972. Our ancestors died or recovered with…
Ten Years of the NIHR: Achievements and Challenges for the Next Decade
1 June 2017
…gathering “real world evidence”; discusses how to demonstrate the value, in terms of both health and wealth, of major NHS investment in R&D; explores how to keep the UK punching…
Working Towards a Sustainable, Healthy Market for Vaccines: a Comprehensive Framework to Support Policy Dialogue and Decision-Making
1 September 2021
By placing a strain on health care systems and the global economy, the COVID-19 pandemic clearly shows the need to more comprehensively understand both supply- and demand-side aspects of a…
The New Global Economics of Vaccines: Will the Scientific Potential Be Realised?
1 January 2007
For the purposes of defining the economic and policy issues facing the vaccine industry, the comments made here are based largely on the experience in the US, but with some…